Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Bio-Rad Laboratories, Inc.

TRADE

NYSE: BIOHealthcare / Medical Laboratories & Research / USA
286.67-1.02-0.35%Vol 24 2531Y Perf 31.07%
Oct 18th, 2018 11:07
BID285.99 ASK286.69
Open288.13 Previous Close287.69
Pre-Market- After-Trading287.69
 - -%  - -%
Target Price
362.50 
Analyst Rating
Moderate Buy 2.20
Potencial %
26.58 
Finscreener Ranking
★★★★★     63.10
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
★★★★★     71.13
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
★★★★★     77.32
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)8 551 
Earnings Rating
Sell
Price Range Ratio 52wk %
55.26 
Earnings Date
1st Nov 2018

Today's Price Range

285.52288.69

52wk Range

214.44345.15

5 Year PE Ratio Range

18.00251.90

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Buy
Performance
1 Month
-3.64%
3 Months
-5.21%
6 Months
8.90%
1 Year
31.07%
3 Years
107.51%
5 Years
135.37%

Quotes

Name / TickerPriceChg.Chg.%
BIO286.67-1.0200-0.35
AAPL218.67-2.5200-1.14
GOOG1 101.03-14.6600-1.31
MSFT109.40-1.3100-1.18
XOM82.080.58000.71
WFC53.97-0.4900-0.90
JNJ138.82-0.6400-0.46
FB156.57-2.8500-1.79
GE12.350.16001.31
JPM109.46-0.3700-0.34
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.80
Current Ratio 4.50
Long Term Debt to Total Capital 0.09
Total Debt to Equity 0.09
Interest Coverage 58.40
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin54.70
EBIT Margin57.10
EBITDA Margin63.50
Pre-tax Profit Margin5.00
Profit Margin58.85
ValuationValueIndustryS&P 500US Markets
PE Ratio 8.20
PB Ratio 1.81
PS Ratios 4.81
Price to Cash Flow 39.30
Price to Free Cash Flow 74.30
Cash Flow Per Share 7.16
Price to Tangible Book2.11
Book Value per Share155.49
Enterprise Value (in ths.)8 093 010
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)3.58
ROE last 12 Months 27.41
Return on Assets (5Y Avg) 1.60
ROA last 12 Months 19.38
Return on Capital (5Y Avg) 3.40
ROC last 12 Months 24.70
Return on invested Capital Q 5.20
Return on invested Capital Y3.89
Assets Turnover0.30
Receivables Turnover4.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 747 860
Revenue per Share 58.58
Revenue Growth 3 Years -1.50
Revenue Growth 5 Years -1.58
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 20181.351.6421.48
Q01 20180.901.1730.00
Q04 20171.281.5017.19
Q03 20170.330.91175.76
Q02 20170.630.58-7.94
Q01 20170.270.4151.85
Q04 20161.001.2525.00
Q03 20160.510.6221.57
Earnings Per EndEstimateRevision %Trend
9/2018 QR1.16-10.08Negative
12/2018 QR2.411.26Positive
12/2018 FY6.382.90Positive
12/2019 FY7.801.83Positive
Next Report Date1st Nov 2018
Estimated EPS Next Report1.16
Estimates Count3
EPS Growth Next 5 Years %15.00
Volume Overview
Volume24 253
Shares Outstanding (in ths.)29 830
Trades Count96
Dollar Volume5 446 136
Avg. Volume149 880
Avg. Weekly Volume138 059
Avg. Monthly Volume164 290
Avg. Quarterly Volume141 955

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (40.00 %)
2 (50.00 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (60.00 %)
2 (50.00 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.20
Moderate Buy
2.00
Moderate Buy
1.67

There are no comments yet.

News

x